Modern cell and gene therapies open up new treatment options, but place high demands on production. Individual patient material requires complex and time-consuming processes. Optima Pharma develops automated, modularly expandable isolator solutions for efficient, economical and future-proof production and filling – from clinical development to commercial manufacturing.